Caxton Associates (New York)’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-60,823
Closed -$1.24M 562
2022
Q2
$1.24M Buy
+60,823
New +$1.5M 0.12% 79
2019
Q2
Sell
-13,172
Closed -$698K 461
2019
Q1
$698K Buy
13,172
+9,212
+233% +$529K 0.1% 103
2018
Q4
$233K Sell
3,960
-4,204
-51% -$232K 0.04% 229
2018
Q3
$445K Buy
+8,164
New +$451K 0.03% 250
2018
Q2
Sell
-18,782
Closed -$915K 417
2018
Q1
$915K Hold
18,782
0.05% 198
2017
Q4
$636K Buy
+18,782
New +$658K 0.03% 257

Other funds holding HLF

Caxton Associates (New York)'s HLF Position: Q3 2022 in Review

Caxton Associates (New York) sold out of Herbalife (HLF) in Q3 2022, closing a stake of 60,823 shares — an estimated $1.24M sold.

Caxton Associates (New York) first reported a position in HLF in Q4 2017 and held it in 6 quarters. The position peaked at $1.24M in Q2 2022. 201 funds tracked by Wall St. Rank hold HLF as of Q3 2022.

  • Caxton Associates (New York) reported no remaining Herbalife position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 60,823 Herbalife shares in Q3 2022, an estimated $1.24M.
  • Caxton Associates (New York) first reported a position in Herbalife in Q4 2017 and held it in 6 quarters.
  • Caxton Associates (New York)'s Herbalife position peaked at $1.24M in Q2 2022.
  • 201 funds tracked by Wall St. Rank held Herbalife as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.